Trial NCT03283046

View at ClinicalTrials.gov 
Org. Study IDs: 2016-0482

Last trial update was posted on 2017-09-20

MeSH Interventions

Dexamethasone Ipilimumab Lenalidomide Nivolumab

MeSH Conditions

Multiple Myeloma Neoplasms Neoplasms, Plasma Cell

Other Conditions

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

Stopping Reasons

Similar to another study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID